Cardio Diagnostics Holdings, Inc. cotiza a 1.78 USD y tiene una capitalización bursátil de $5M. En los últimos 12 meses ha facturado $14450 con un margen de flujo de caja libre del -39893.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated …
| Periodo | 2026-08 | 2025-05 | 2025-03 | 2024-11 |
|---|---|---|---|---|
| Real | — | $-0.97 | $-0.30 | $-1.80 |
| Estimado | — | $-1.80 | $-1.80 | $-1.50 |
| Sorpresa | — | +46.1% | +83.3% | -20.0% |
| Métrica | CDIO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -43737.5% | -38.6% | -43698.8% |
| Net Margin | -43832.5% | -33.6% | -43798.9% |
| FCF Margin | -39893.1% | -13.9% | -39879.2% |
| ROE | -93.2% | -40.4% | -52.8% |
| ROA | -83.7% | -32.0% | -51.7% |
| Current Ratio | 9.79 | 2.84 | +6.95 |
| Debt / Equity | — | 0.28 | — |